ea0016p352 | Growth and development | ECE2008
Savastio Silvia
, Bellone Simonetta
, Bellone Jaele
, Zanetta Fiorella
, Di Dio Giuseppina
, Giacoma Sara
, Petri Antonella
, Prodam Flavia
, Corneli Ginevra
, Bona Gianni
, Aimaretti Gianluca
Introduction: Therapy with recombinant GH (rhGH) allows GH-deficient children (GHD) to reach an adequate adult stature. Previous studies have reported a significant rise in serum insulin levels during GH therapy. It has been demonstrated that insulin resistance is a risk factor for the development of DMT2, atherosclerosis, dyslipidemia and hypertension.Subjects and methods: Aim of our study was to evaluate changes in insulin sensitivity in a group of GHD...